2019
DOI: 10.1186/s12911-019-0944-3
|View full text |Cite
|
Sign up to set email alerts
|

A novel hybrid modeling approach for the evaluation of integrated care and economic outcome in heart failure treatment

Abstract: BackgroundDemographic changes, increased life expectancy and the associated rise in chronic diseases pose challenges to public health care systems. Optimized treatment methods and integrated concepts of care are potential solutions to overcome increasing financial burdens and improve quality of care. In this context modeling is a powerful tool to evaluate potential benefits of different treatment procedures on health outcomes as well as health care budgets. This work presents a novel modeling approach for simu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 41 publications
(45 reference statements)
0
4
0
Order By: Relevance
“…Highly illustrative investigations were proposed by Lassnig at al. [8]. Other clinical prediction models (CPMs), also known as clinical prediction scores or rules, are used to estimate the risk of an existing disease (diagnostic prediction model) or future outcomes (prognostic prediction model) for a given individual and consist of analyzing the values of numerous predictors (prognostic or risk factors), such as age, sex, and biomarkers [9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Highly illustrative investigations were proposed by Lassnig at al. [8]. Other clinical prediction models (CPMs), also known as clinical prediction scores or rules, are used to estimate the risk of an existing disease (diagnostic prediction model) or future outcomes (prognostic prediction model) for a given individual and consist of analyzing the values of numerous predictors (prognostic or risk factors), such as age, sex, and biomarkers [9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, it is also important to be able to simulate on a both long and short timescale, since it is only via short-term simulations (days-months) that one can compare predictions with observed changes and thus gain more faith in the models, and since it is only via long-term simulations (years-decades) that risks are substantially altered. Finally, as mentioned in the introduction, there are some, but not many, hybrid models in biomedicine already available (20)(21)(22)(23)(24)(25)(26)(27), but no other model exists for multi-scale simulations of stroke risk.…”
Section: The New Hybrid Modelmentioning
confidence: 99%
“…drugs) (26). Within the field of cardiovascular diseases specifically, a hybrid model that combines a discrete model with an agent-based model has been used to simulate treatment procedures of heart failure and comparing both health outcomes and financial aspects (27). However, despite these many suggestions and first examples, and despite the importance of developing digital twins for stroke, no hybrid model underlying digital twins for stroke has yet been developed.…”
Section: Introductionmentioning
confidence: 99%
“…In the case of stroke care and within the context of precision medicine for stroke, a hybrid modeling approach has been shown to be the most beneficial [ 7 ]. The application of hybrid modeling has also been observed in the field of cardiovascular diseases; hybrid modeling approaches have been used to assess integrated care for challenging and complex diseases to offer comprehensive tools for decision-making [ 8 ].…”
Section: Introductionmentioning
confidence: 99%